The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice
Molecular Pharmacology · 2025
DOI: 10.1016/j.molpha.2025.100065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Man Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Cente…. Hauptthemen laut MEDLINE: PPAR alpha, PPAR gamma, Fatty Liver, PPAR-beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hebei Provincial Department of Human Resources and Social Security.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China; Key Laboratory fo…
- New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; Hebei Industry Microbial Metabolic Technology Innovation Center, Shijiazhuang, Hebei, China.
- New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China.
- New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; Key Laboratory for New Drug Screening Technology of Shijiazhuang City, Shijiazhuang, Hebei, China; Hebei…
- Life Science of College, Hebei Normal University, Shijiazhuang, Hebei, China.
- New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang, Hebei, China; National Engineering Research Center of Microbial Medicine, Shijiazhuang, Hebei, China; Hebei Industry Mi…
Förderung
- Hebei Provincial Department of Human Resources and Social Security
Zitieren
APA
Yu, M., Ren, X., Li, R., Shen, W., Zhao, B., Li, Y., Zhang, X., Cui, X., Zhu, J., Zhang, X., Wang, L., Lu, X., & Zheng, Z. (2025). The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100065
Vancouver
Yu M, Ren X, Li R, Shen W, Zhao B, Li Y, et al. The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100065
BibTeX
@article{Yu2025,
author = {Yu, Man and Ren, Xiao and Li, Ruolan and Shen, Wenbin and Zhao, Baohua and Li, Yeying and Zhang, Xuelian and Cui, Xiaolan and Zhu, Jingtong and Zhang, Xuexia and Wang, Lijie and Lu, Xinhua and Zheng, Zhihui},
title = {The peroxisome proliferator–activated receptor α/β/γ agonist NCPC-626 from microbial metabolites alleviates metabolic dysfunction–associated steatohepatitis in mice},
journal = {Molecular Pharmacology},
year = {2025},
doi = {10.1016/j.molpha.2025.100065}
}
EUVIMED